Fusion partners for peptide production
US10981968B2 · kind B2 · utility
0Cited by
41References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2018 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Sep 19, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to the field of medicine, in particular, to the production of large amounts of a soluble recombinant polypeptide as part of a fusion protein comprising an N-terminal fusion partner linked to the polypeptide of interest.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.